P-1421. Impact of a Community Health Worker and Pharmacist Led Vaccine Gap Closure Program in Missouri
Adriana Gardner, John Galdo, Jasmine Gonzalvo, Annie Eisenbeis, Rakhi Karwa

TL;DR
A Missouri program led by pharmacists and community health workers successfully increased vaccination rates by addressing hesitancy and cost barriers.
Contribution
Demonstrates the effectiveness of pharmacist and CHW-led vaccination programs in overcoming geographic and socioeconomic barriers.
Findings
81.4% of encounters resulted in at least one vaccine being administered.
Vaccine hesitancy counseling led to vaccines being administered 64% of the time.
Financial insecurity and lack of insurance were major social barriers addressed by the program.
Abstract
Significant gaps in vaccination rates exist, with only 22.8% of US adults receiving all age-appropriate vaccines in 2022. As trusted community members, community health workers (CHWs) are uniquely positioned to address vaccine hesitancy and provide culturally appropriate services. A statewide Missouri community vaccination program led by pharmacists and CHWs was implemented to overcome barriers to vaccination by delivering vaccines outside clinic settings, addressing vaccine hesitancy, and covering costs when needed. This study analyzed the impact of this vaccination initiative. A retrospective review of clinical records from the Missouri community vaccination program was conducted. Patients were included if they had ≥ 1 encounter with the program. Descriptive statistics were used to characterize patient demographics, social needs, and the types of vaccines given. The primary outcome…
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVaccine Coverage and Hesitancy · Intramuscular injections and effects · Health Systems, Economic Evaluations, Quality of Life
